-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Landos Biopharma, Inc. quarterly and annual General and Administrative Expense in USD history and change rate from 31 Mar 2020 to 31 Mar 2024.
- Landos Biopharma, Inc. General and Administrative Expense for the quarter ending 31 Mar 2024 was $6,144,000, a 95% increase year-over-year.
- Landos Biopharma, Inc. General and Administrative Expense for the twelve months ending 31 Mar 2024 was $13,719,000, a 1.2% decline year-over-year.
- Landos Biopharma, Inc. annual General and Administrative Expense for 2023 was $10,728,000, a 28% decline from 2022.
- Landos Biopharma, Inc. annual General and Administrative Expense for 2022 was $14,881,000, a 2.4% decline from 2021.
- Landos Biopharma, Inc. annual General and Administrative Expense for 2021 was $15,252,000, a 186% increase from 2020.